114 related articles for article (PubMed ID: 981969)
1. Reversible activation of proactivator (factor B) of the alternative pathway without cleavage of the molecule.
Day NK; Schreiber RD; Götze O; Müller-Eberhard HJ
Scand J Immunol; 1976; 5(6-7):715-20. PubMed ID: 981969
[TBL] [Abstract][Full Text] [Related]
2. Properdin: initiation of alternative complement pathway.
Fearon DT; Austen KF
Proc Natl Acad Sci U S A; 1975 Aug; 72(8):3220-4. PubMed ID: 1059108
[TBL] [Abstract][Full Text] [Related]
3. Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway.
Medicus RG; Götze O; Müller-Eberhard HJ
J Exp Med; 1976 Oct; 144(4):1076-93. PubMed ID: 978134
[TBL] [Abstract][Full Text] [Related]
4. Properdin- and nephritic factor-dependent C3 convertases: requirement of native C3 for enzyme formation and the function of bound C3b as properdin receptor.
Schreiber RD; Medicus RG; Gïtze O; Müller-Eberhard HJ
J Exp Med; 1975 Sep; 142(3):760-72. PubMed ID: 1165475
[TBL] [Abstract][Full Text] [Related]
5. Evidence for the presence of components of the alternative (properdin) pathway of complement activation in respiratory secretions.
Robertson J; Caldwell JR; Castle JR; Waldman RH
J Immunol; 1976 Sep; 117(3):900-3. PubMed ID: 956659
[TBL] [Abstract][Full Text] [Related]
6. A molecular concept of the properdin pathway.
Medicus RG; Schreiber RD; Götze O; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1976 Feb; 73(2):612-6. PubMed ID: 54923
[TBL] [Abstract][Full Text] [Related]
7. C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertase.
Daha MR; Fearon DT; Austen KF
J Immunol; 1976 Jan; 116(1):1-7. PubMed ID: 1245733
[TBL] [Abstract][Full Text] [Related]
8. Cleavage of the third complement component (C3) and generation of the spasmogenic peptide, C3a, in human serum via the properdin pathway: demonstration of inhibitory as well as enhancing effects of epsilon-amino-caproic acid.
Vogt W; Schmidt G; Lynen R; Dieminger L
J Immunol; 1975 Feb; 114(2 Pt 1):671-7. PubMed ID: 804510
[TBL] [Abstract][Full Text] [Related]
9. Formation and composition of the C3 activating enzyme complex of the properdin system. Sequential assembly of its components on solid-phase trypsin-agarose.
Vogt W; Schmidt G; Dieminger L; Lynen R
Z Immunitatsforsch Exp Klin Immunol; 1975 Jul; 149(5):440-55. PubMed ID: 126576
[TBL] [Abstract][Full Text] [Related]
10. Activation of the alternative complement pathway with rabbit erythrocytes by circumvention of the regulatory action of endogenous control proteins.
Fearon DT; Austen KF
J Exp Med; 1977 Jul; 146(1):22-33. PubMed ID: 559720
[TBL] [Abstract][Full Text] [Related]
11. Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase.
Fearon DT; Austen KF
J Exp Med; 1975 Oct; 142(4):856-63. PubMed ID: 1185108
[TBL] [Abstract][Full Text] [Related]
12. Alternative pathway of complement: demonstration and characterization of initiating factor and its properdin-independent function.
Schreiber RD; Götze O; Müller-Eberhard HJ
J Exp Med; 1976 Oct; 144(4):1062-75. PubMed ID: 62010
[TBL] [Abstract][Full Text] [Related]
13. Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.
Fearon DT; Daha MR; Strom TB; Weiler JM; Carpenter CB; Austen KF
Transplant Proc; 1977 Mar; 9(1):729-39. PubMed ID: 325806
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin and complement deposits in lupus glomerulonephritis.
Méry JP; Morel-Maroger L; Boelaert J
Proc Eur Dial Transplant Assoc; 1975; 11():506-11. PubMed ID: 1197274
[No Abstract] [Full Text] [Related]
15. Factor B of the alternative complement pathway on human lymphocytes.
Halbwachs L; Lachmann PJ
Scand J Immunol; 1976; 5(6-7):697-704. PubMed ID: 824718
[TBL] [Abstract][Full Text] [Related]
16. Immunofluorescence patterns in chronic membranoproliferative glomerulonephritis (MPGN).
Belgiojoso GB; Tarantino A; Bazzi C; Colasanti G; Guerra L; Durante A
Clin Nephrol; 1976 Jul; 6(1):303-10. PubMed ID: 782750
[TBL] [Abstract][Full Text] [Related]
17. Interaction of zymosan and of activated properdin with factor D-depleted guinea pig serum: implications for the mechanism of initial C3 cleavage via the alternative complement pathway.
Brade V; Bentley C; Bitter-Suermann D; Hadding U
Z Immunitatsforsch Immunobiol; 1977 Feb; 152(5):402-14. PubMed ID: 556571
[TBL] [Abstract][Full Text] [Related]
18. Structure and function of recombinant cobra venom factor.
Kock MA; Hew BE; Bammert H; Fritzinger DC; Vogel CW
J Biol Chem; 2004 Jul; 279(29):30836-43. PubMed ID: 15131128
[TBL] [Abstract][Full Text] [Related]
19. The association of respiratory infection, recurrent hematuria, and focal glomerulonephritis with activation of the complement system in the cold.
Day NK; Geiger H; McLean R; Resnick J; Michael A; Good RA
J Clin Invest; 1973 Jul; 52(7):1698-706. PubMed ID: 4198109
[TBL] [Abstract][Full Text] [Related]
20. Requirements for the solubilization of immune aggregates by complement: assembly of a factor B-dependent C3-convertase on the immune complexes.
Takahashi M; Tack BF; Nussenzweig V
J Exp Med; 1977 Jan; 145(1):86-100. PubMed ID: 830792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
